Drug intelligence / Profile preview

Suncure Xt

Development stage: Unknown
Lead developer: Suncure Lifescience
Modality: Small Molecules
Administration: Oral

Overview

**Suncure Xt** is an oral fixed-dose antianemic tablet marketed by Suncure Lifescience. The product is identified by its sponsor as containing ferrous ascorbate and folic acid, providing iron replacement and folate supplementation to treat or prevent iron deficiency anemia. ([suncurelife.com](https://www.suncurelife.com/Product-Detail/Suncure%20Xt%20Tablet))

Brand names: Suncure Xt
Other names: Suncure XTSUNCURE-XT

Beyond the preview

Go deeper on Suncure Xt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suncure Xt.

Explore the full profile